| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
L1 cell adhesion molecule | 0.475 | 0.769 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
glutaminase | 0.489 | 0.808 | 0.96 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 2 | 0.445 | 0.923 | 1.4E-02 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
TNF receptor superfamily member 8 | 0.444 | 0.808 | 0.86 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
microRNA 935 | 0.695 | 0.192 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
TNRC6C antisense RNA 1 | 0.705 | 0.346 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
LY75-CD302 readthrough | 0.711 | 0.423 | 7.4E-46 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
kinesin family member 20A | 0.615 | 0.615 | 4.5E-13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
TNF receptor associated protein 1 | 0.590 | 0.615 | 1.6E-29 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
reactive intermediate imine deaminase A homolog | 0.606 | 0.769 | 6.8E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
STIP1 homology and U-box containing protein 1 | 0.544 | 0.692 | 1.9E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
anterior gradient 2, protein disulphide isomerase family member | 0.556 | 0.692 | 9.2E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
leukocyte immunoglobulin like receptor B1 | 0.510 | 0.769 | 5.7E-14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
PR/SET domain 5 | 0.621 | 0.654 | 3.6E-10 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
chromogranin B | 0.599 | 0.654 | 2.4E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
three prime repair exonuclease 1 | 0.517 | 0.808 | 0.58 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
tumor suppressor 2, mitochondrial calcium regulator | 0.556 | 0.846 | 0.77 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
antizyme inhibitor 2 | 0.499 | 0.808 | 8.9E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
BPI fold containing family A member 2 | 0.608 | 0.808 | 8.0E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
FEZF1 antisense RNA 1 | 0.644 | 0.615 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ephrin A2 | 0.686 | 0.462 | 3.8E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
AT-rich interaction domain 2 | 0.543 | 0.808 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cortactin | 0.546 | 0.769 | 8.9E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |